Attached files
| file | filename |
|---|---|
| EX-23.2 - EXHIBIT 23.2 PWC - SEELOS THERAPEUTICS, INC. | apri123115ex232pwc.htm |
| EX-32.2 - EXHIBIT 32.2 - SEELOS THERAPEUTICS, INC. | apri123115ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | apri123115ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC. | apri123115ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | apri123115ex311.htm |
| EX-23.1 - EXHIBIT 23.1 BDO - SEELOS THERAPEUTICS, INC. | apri123115ex231bdo.htm |
| 10-K - APRI 2015 10-K - SEELOS THERAPEUTICS, INC. | apri12311510k.htm |
Exhibit 21
SUBSIDIARIES OF APRICUS BIOSCIENCES, INC.
1. | NexMed (U.S.A.), Inc., incorporated in Delaware on June 18, 1997. |
2. | Apricus Pharmaceuticals USA, Inc. (formerly Topotarget USA, Inc.), incorporated in Delaware on July 12, 2006 and acquired by Apricus Biosciences, Inc. on December 29, 2011. |
3. | NexMed Holdings, Inc., incorporated in Delaware on February 28, 1997. |
4. | NexMed International Limited, incorporated in the British Virgin Islands on August 2, 1996. |